Lötsch D - Search Results

1

Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression.

Englinger B, Lötsch D, Pirker C, Mohr T, van Schoonhoven S, Boidol B, Lardeau CH, Spitzwieser M, Szabó P, Heffeter P, Lang I, Cichna-Markl M, Grasl-Kraupp B, Marian B, Grusch M, Kubicek S, Szakács G, Berger W. Englinger B, et al. Among authors: lotsch d. Oncotarget. 2016 Aug 2;7(31):50161-50179. doi: 10.18632/oncotarget.10324. Oncotarget. 2016. PMID: 27367030 Free PMC article.

2

Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts.

Sturtzel C, Grissenberger S, Bozatzi P, Scheuringer E, Wenninger-Weinzierl A, Zajec Z, Dernovšek J, Pascoal S, Gehl V, Kutsch A, Granig A, Rifatbegovic F, Carre M, Lang A, Valtingojer I, Moll J, Lötsch D, Erhart F, Widhalm G, Surdez D, Delattre O, André N, Stampfl J, Tomašič T, Taschner-Mandl S, Distel M. Sturtzel C, et al. Among authors: lotsch d. NPJ Precis Oncol. 2023 May 18;7(1):44. doi: 10.1038/s41698-023-00386-9. NPJ Precis Oncol. 2023. PMID: 37202469 Free PMC article. Review.

3

O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.

Spiegl-Kreinecker S, Pirker C, Filipits M, Lötsch D, Buchroithner J, Pichler J, Silye R, Weis S, Micksche M, Fischer J, Berger W. Spiegl-Kreinecker S, et al. Among authors: lotsch d. Neuro Oncol. 2010 Jan;12(1):28-36. doi: 10.1093/neuonc/nop003. Epub 2009 Oct 15. Neuro Oncol. 2010. PMID: 20150365 Free PMC article.

4

Response of experimental malignant melanoma models to the pan-Aurora kinase inhibitor VE-465.

Pirker C, Lötsch D, Spiegl-Kreinecker S, Jantscher F, Sutterlüty H, Micksche M, Grusch M, Berger W. Pirker C, et al. Among authors: lotsch d. Exp Dermatol. 2010 Dec;19(12):1040-7. doi: 10.1111/j.1600-0625.2010.01182.x. Exp Dermatol. 2010. PMID: 21087322

5

The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells.

Losert A, Lötsch D, Lackner A, Koppensteiner H, Peter-Vörösmarty B, Steiner E, Holzmann K, Grunt T, Schmid K, Marian B, Grasl-Kraupp B, Schulte-Hermann R, Krupitza G, Berger W, Grusch M. Losert A, et al. Among authors: lotsch d. Cancer Lett. 2012 Jun 28;319(2):164-172. doi: 10.1016/j.canlet.2012.01.002. Epub 2012 Jan 17. Cancer Lett. 2012. PMID: 22261339

6

Trabectedin has promising antineoplastic activity in high-grade meningioma.

Preusser M, Spiegl-Kreinecker S, Lötsch D, Wöhrer A, Schmook M, Dieckmann K, Saringer W, Marosi C, Berger W. Preusser M, et al. Among authors: lotsch d. Cancer. 2012 Oct 15;118(20):5038-49. doi: 10.1002/cncr.27460. Epub 2012 Mar 5. Cancer. 2012. PMID: 22392434 Free article.

7

Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation.

Mathieu V, Pirker C, Schmidt WM, Spiegl-Kreinecker S, Lötsch D, Heffeter P, Hegedus B, Grusch M, Kiss R, Berger W. Mathieu V, et al. Among authors: lotsch d. Oncotarget. 2012 Apr;3(4):399-413. doi: 10.18632/oncotarget.473. Oncotarget. 2012. PMID: 22535842 Free PMC article.

8

Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

Lötsch D, Steiner E, Holzmann K, Spiegl-Kreinecker S, Pirker C, Hlavaty J, Petznek H, Hegedus B, Garay T, Mohr T, Sommergruber W, Grusch M, Berger W. Lötsch D, et al. Oncotarget. 2013 Nov;4(11):1904-18. doi: 10.18632/oncotarget.1264. Oncotarget. 2013. PMID: 24243798 Free PMC article.

9

Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.

Spiegl-Kreinecker S, Lötsch D, Ghanim B, Pirker C, Mohr T, Laaber M, Weis S, Olschowski A, Webersinke G, Pichler J, Berger W. Spiegl-Kreinecker S, et al. Among authors: lotsch d. Neuro Oncol. 2015 Sep;17(9):1231-40. doi: 10.1093/neuonc/nov010. Epub 2015 Feb 13. Neuro Oncol. 2015. PMID: 25681309 Free PMC article.

10

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.

Sevelda F, Mayr L, Kubista B, Lötsch D, van Schoonhoven S, Windhager R, Pirker C, Micksche M, Berger W. Sevelda F, et al. Among authors: lotsch d. J Exp Clin Cancer Res. 2015 Nov 2;34:134. doi: 10.1186/s13046-015-0251-5. J Exp Clin Cancer Res. 2015. PMID: 26526352 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters